Molecule to Market Podcast: Ray Kaczmarek

Scroll Down

On a recent episode of the Molecule to Market podcast, Genezen’s CEO Ray Kaczmarek joined as a guest discussing insights into the booming cell and gene therapy space and how it will change the way we view medicine as a cure, not a treatment. He also speaks about the up-and-coming life science hub of Fishers, Indianapolis and Genezen’s own plans for current and continued growth.

Listen to the full episode here

You may also be interested in...

ARM A-Cell: New guidance incorporates quality…

Lentiviruses are an essential tool for many cell and gene therapies...

Read more

Overcoming challenges in gammaretroviral vector development…

Rapid expansion in biotechnology platforms and advancement in genetic editing technologies...

Read more

3 trends in lentivirus development and…

The growth of the cell and gene therapy (C&GT) space, and...

Read more

A trend towards gammaretrovirus in cell…

What’s driving the trending preference for gammaretroviral vectors in C&GT? As...

Read more